治療用注射剤：装置、製品、市場

当レポートは、治療用注射剤市場について調査し、市場の概要とともに、セグメント別動向、新興技術動向、市場の予測、および市場に参入する企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

• 市場機会
• 配送市場力学
• 注射薬の経済学
• 注射デバイスの成長促進要因
• プレフィルドシリンジの急増
• プレフィルドシリンジのサプライチェーン
• 自己管理の傾向
• 人口動態の変化
• ディスポーザブルデバイス設計の革新
• 生物学的製剤の蔓延
• 治療用モノクローナル抗体
• 危険因子
• 注射剤装置の概要
• オートインジェクター

単回固定用量

可変投与量

デュアルチャンバー

ワイヤレス対応のオートインジェクター

• BETACONNECT（バイエル）
• RebiSmart（メルクセローノ）

主要製品

オートインジェクター

オートインジェクターデバイスの設計要素

• 材料選択の問題
• 部品数とデバイスのコスト
• 安全機能
• 針挿入深さ
• フェールセーフアクティベーション
• 容量検査・注射確認

市場要因

• 凍結乾燥薬剤/再構成
• 人間工学/人間工学

ペン型インジェクター

商用ペン製品

副甲状腺ホルモン

• フォルテオペン
• プレオタクト/プレオス
• ナッパラ

生殖ホルモン

• フォリスティム/ピュアゴンペン
• ゴナルエフ

ウェアラブルデバイス- 分析と評価

新興技術

• ワイヤレスデータ

注射剤市場の分析と予測

• 自己免疫疾患
  • 関節リウマチ
  • 乾癬
  • 多発性硬化症
• 造血学
  • ホルモン
  • 骨粗鬆症
  • 受胎能力

市場要因

• 規制の問題
• 装置のブランディング
• 患者のアドヒアランスと使いやすさ
• ヘルスケア経済学

企業プロファイル

“Therapeutic Injectable Drug: Devices, Products and Markets” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for therapeutic injectable drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

What You Will Learn:

• Provides detailed analysis of injectable drug products, drug delivery and device strategies, and product development factors.

• Assesses key markets, market dynamics and market demographics.

• Analyzes therapeutic demand drivers and evaluates injectable drug products in nine key therapeutic segments.

• Provides market data and forecasts.

• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations

• Assesses the importance of alliances and partnerships on drug product commercialization.

• Evaluates the impact of economic, technology, and regulatory factors.

Table of Contents

Executive Summary

• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Prefilled Syringe Supply Chain
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs
• Proliferation of Biological Drugs
• Therapeutic Monoclonal Antibodies
• Risk Factors
• Injectable Drug Device Summaries
• Autoinjectors

Single Fixed Dose

• Molly (SHL Medical)
• Molly RNS (SHLMedical)
• Bertha (SHL Medical)
• Maggie (SHL Medical)
• Amber (SHL Medical)
• AutoJect 2 (Owen Mumford)
• SelfDose (West Pharmaceutical Services)
• DAI (SHL Medical)
• DI 2 (SHL medical)
• Flexi-Q PFS (Elcam Medical)
• Physioject (Becton DIckinson
• Intevia (Becton Dickinson)

Variable Dosing

• VSDI + NIT
• Ypsomed VarioJect
• High Viscosity
• Rotaject Technology (SHL Medical)
• Ypsomed/Ypsomed 2.25)
• Flexi-Q HV (Elcam Medical)

Dual Chamber

Wirelessly Enabled Autoinjectors

• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)

Selected Product Specific

Autoinjectors

• Alsuma/Sumatriptan Autoinjector
• Sumatriptan (Dr. Reddy's)
• Rebif/Rebidose (Merck Serono)
• Aimovig (Amgen/Novartis)
• Enbrel Mini AutoTouch (Amgen)
• Pegasys Proclick (Genentech/Roche)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)

Autoinjector Device Design Factors

• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation

Market Factors

• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics

Pen Injectors

• Pen Injector Design Selection Factors
• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• Custom Pen Designs
• Reusable Pens
• Dual Chamber Pens

Commercial Pen Products

• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• NordiPenmate
• Nutropin AQ Pen
• Omnitrope
• One.Click
• Lantus/Toujeo (Insulin Glargine)
• Diapen
• Gansulin Pen
• Flexpen (Novo Nordisk)
• Humalog Pen/KwikPen
• HumaPen Memoir
• HumaPen Luxura HD
• NovoPen (Novo Nordisk)
• SoloStar
• Byetta Pen
• Bydureon
• SymlinPen
• Saxenda (Liraglutide)
• Tanzeum (Abliglutide)
• Trulicity (Dulaglutide)
• Victoza (Liraglutide)

Parathyroid Hormone

• Forteo Pen
• Preotact/Preos
• Natpara

Reproductive Hormones

• Follistim/Puregon Pen
• Gonal-f

Wearable Devices - Analysis and Assessments

• Libertas (Becton Dickinson)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• eLVD Patch Pump (Elcam)

Emerging Technology

• Wireless Data

Injectable Drug Market Analysis and Forecasts

• Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis

• Hematopoietics
  • Hormones
  • Osteoporosis
  • Fertility

Market Factors

• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics

Company Profiles